Since 1995, Bactiguard has been a successful licensing partner with the global medical device company CR Bard, now BD (Becton Dickinson). BD acquired CR Bard in 2017 to become stronger within the area of infection prevention. BD markets Bactiguard coated urinary catheters under the brands Bardex IC and Lubrisil IC in the United States, Japan, UK, Ireland, Canada and Australia.
Zimmer Biomet, USA
In September 2019 we signed a global license agreement for orthopaedic trauma implants with the US company Zimmer Biomet. Zimmer Biomet is one of the world’s largest orthopaedic companies. This license agreement entitles Zimmer Biomet to use our technology to coat and sell orthopaedic trauma implants globally and can be expanded to include other applications.
Well Lead Medical, China
Well Lead is today China’s largest and one of the world’s leading manufacturers of medical devices such as urinary catheters and endotracheal tubes. Since 2018 they have the exclusive right to sell and distribute Bactiguard’s urinary catheters (BIP Foley) in China. Well Lead has completed the preparatory work to register our entire portfolio of products in China, which means that in a few years’ time they will manufacture and sell all products in the Bactiguard portfolio in the Chinese market.